Suppr超能文献

评估挪威样本中 BRCA1 或 BRCA2 基因检测后患者对再次联系的偏好与其监测应对方式之间的关系。

Assessing the relationship between patient preferences for recontact after BRCA1 or BRCA2 genetic testing and their monitoring coping style in a Norwegian sample.

机构信息

Department of Medical Genetics, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway.

Department of Global Health and Primary Care, University of Bergen, Bergen, Norway.

出版信息

J Genet Couns. 2022 Apr;31(2):554-564. doi: 10.1002/jgc4.1526. Epub 2021 Oct 30.

Abstract

Recontacting former patients regarding new genetic information is currently not standard care but might be implemented in the future. Little information is available on the implications of this practice from the point of view of former patients. The aim of this study was to investigate preferences for recontact when new genetic information becomes available among patients tested for BRCA pathogenic variants. We further wanted to investigate whether having a high or low information-seeking coping style (monitoring) impacts preferences. Preferences for recontact were assessed using a self-constructed questionnaire. The Threatening Medical Situations Inventory (TMSI) was used to measure monitoring coping style. The questionnaires were sent to 500 randomly selected patients who had previously been tested for BRCA pathogenic variants within the time frame 2001-2014 at one genetic clinic in Norway. We received 323 completed questionnaires. Most respondents wanted to be recontacted with advances in genetic medicine (81.1%) and to receive highly personalized updates. Genetic counselors/geneticists were believed to be most responsible for recontact. There was a significant relationship between being a high monitor and wanting recontact to learn about own cancer risk and receive ongoing support. Patients have a high interest in being recontacted. The findings indicated a tendency for high monitors to prefer more detailed and personalized information.

摘要

重新联系以前的患者以提供新的遗传信息目前并非标准护理措施,但将来可能会实施。从以前患者的角度来看,有关这种做法的影响的信息很少。本研究的目的是调查当可获得有关 BRCA 致病性变异的新遗传信息时,检测过 BRCA 致病性变异的患者对重新联系的偏好。我们还想调查具有高或低信息寻求应对方式(监测)是否会影响偏好。使用自我构建的问卷评估重新联系的偏好。使用威胁医疗情况量表(TMSI)来衡量监测应对方式。调查问卷发送给了 500 名在挪威一家遗传诊所于 2001-2014 年期间接受过 BRCA 致病性变异检测的随机选择的患者。我们收到了 323 份完整的问卷。大多数受访者希望在遗传医学取得进展时被重新联系(81.1%),并收到高度个性化的更新。遗传咨询师/遗传学家被认为是最有责任重新联系的人。高监测者与希望重新联系以了解自身癌症风险并获得持续支持之间存在显著关系。患者对被重新联系有很高的兴趣。研究结果表明,高监测者倾向于更详细和个性化的信息。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验